Impact of obesity on the survival of patients with early-stage squamous cell carcinoma of the oral tongue

Cancer

Volumn 120, Issue 7, 2014, Pages 983-991

  Iyengar, Neil M ^a   Kochhar, Amit ^b,c   Morris, Patrick G ^a   Morris, Luc G ^a   Zhou, Xi K ^b   Ghossein, Ronald A ^a   Pino, Alejandro ^a   Fury, Matthew G ^a   Pfister, David G ^a   Patel, Snehal G ^a   Boyle, Jay O ^a   Hudis, Clifford A ^a   Dannenberg, Andrew J ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

body mass index; head and neck neoplasms; obesity; prognosis; squamous cell carcinoma of the head and neck; tongue neoplasms

Indexed keywords

PROTEIN P16;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANCER GRADING; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; NUTRITIONAL ASSESSMENT; OBESITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; TUMOR INVASION; VERY ELDERLY; WEIGHT REDUCTION;

BODY MASS INDEX; HEAD AND NECK NEOPLASMS; OBESITY; PROGNOSIS; SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK; TONGUE NEOPLASMS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OBESITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TONGUE NEOPLASMS; YOUNG ADULT;

EID: 84899416864     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28532     Document Type: Article

References (42)

1. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63: 11-30.
2. Depue RH,. Rising mortality from cancer of the tongue in young white males. N Engl J Med. 1986; 315: 647.
3. Salem A,. Dismissing links between HPV and aggressive tongue cancer in young patients. Ann Oncol. 2010; 21: 13-17.
4. Saba NF, Goodman M, Ward K, et al. Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and end results program-based analysis. Oncology. 2011; 81: 12-20.
5. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010; 363: 24-35.
6. Dahlgren L, Dahlstrand HM, Lindquist D, et al. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer. 2004; 112: 1015-1019.
7. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML,. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008; 26: 612-619.
8. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000; 92: 709-720.
9. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007; 356: 1944-1956.
10. Herrero R, Castellsague X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003; 95: 1772-1783.
11. Gaudet MM, Olshan AF, Chuang SC, et al. Body mass index and risk of head and neck cancer in a pooled analysis of case-control studies in the International Head and Neck Cancer Epidemiology (INHANCE) Consortium. Int J Epidemiol. 2010; 39: 1091-1102.
12. Kreimer AR, Randi G, Herrero R, et al. Diet and body mass, and oral and oropharyngeal squamous cell carcinomas: analysis from the IARC multinational case-control study. Int J Cancer. 2006; 118: 2293-2297.
13. Rodriguez T, Altieri A, Chatenoud L, et al. Risk factors for oral and pharyngeal cancer in young adults. Oral Oncol. 2004; 40: 207-213.
14. Nieto A, Sanchez MJ, Martinez C, et al. Lifetime body mass index and risk of oral cavity and oropharyngeal cancer by smoking and drinking habits. Br J Cancer. 2003; 89: 1667-1671.
15. Franceschi S, Dal Maso L, Levi F, Conti E, Talamini R, La Vecchia C,. Leanness as early marker of cancer of the oral cavity and pharynx. Ann Oncol. 2001; 12: 331-336.
16. Kabat GC, Chang CJ, Wynder EL,. The role of tobacco, alcohol use, and body mass index in oral and pharyngeal cancer. Int J Epidemiol. 1994; 23: 1137-1144.
17. D'Avanzo B, La Vecchia C, Talamini R, Franceschi S,. Anthropometric measures and risk of cancers of the upper digestive and respiratory tract. Nutr Cancer. 1996; 26: 219-227.
18. Liu SA, Tsai WC, Wong YK, et al. Nutritional factors and survival of patients with oral cancer. Head Neck. 2006; 28: 998-1007.
19. van Bokhorst-de van der Schuen MA, van Leeuwen PA, Kuik DJ, et al. The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer. 1999; 86: 519-527.
20. Nguyen TV, Yueh B,. Weight loss predicts mortality after recurrent oral cavity and oropharyngeal carcinomas. Cancer. 2002; 95: 553-562.
21. van Kruijsdijk RC, van der Wall E, Visseren FL,. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev. 2009; 18: 2569-2578.
22. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ,. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003; 348: 1625-1638.
23. Yoon HH, Lewis MA, Shi Q, et al. Prognostic impact of body mass index stratified by smoking status in patients with esophageal adenocarcinoma. J Clin Oncol. 2011; 29: 4561-4567.
24. Sinicrope FA, Foster NR, Sargent DJ, O'Connell MJ, Rankin C,. Obesity is an independent prognostic variable in colon cancer survivors. Clin Cancer Res. 2010; 16: 1884-1893.
25. Sinicrope FA, Foster NR, Yoon HH, et al. Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trials. J Clin Oncol. 2012; 30: 406-412.
26. Meyerhardt JA, Tepper JE, Niedzwiecki D, et al. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. J Clin Oncol. 2004; 22: 648-657.
27. Meyerhardt JA, Ma J, Courneya KS,. Energetics in colorectal and prostate cancer. J Clin Oncol. 2010; 28: 4066-4073.
28. Levi J, Segal LM, St. Laurent R, Lang A, Rayburn J,. F as in Fat: How Obesity Threatens America's Future 2012. http://healthyamericans.org/assets/ files/TFAH2012FasInFatFnlRv.pdf. Accessed September 28, 2012. Published September 2012.
29. Bishop JA, Westra WH,. Human papillomavirus-related small cell carcinoma of the oropharynx. Am J Surg Pathol. 2011; 35: 1679-1684.
30. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr,. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999; 341: 1097-1105.
31. Ragin CC, Langevin SM, Marzouk M, Grandis J, Taioli E,. Determinants of head and neck cancer survival by race. Head Neck. 2011; 33: 1092-1098.
32. Nieto A, Sanchez MJ, Quintana MJ, et al. BMI throughout life, intake of vitamin supplements and oral cancer in Spain. IARC Sci Publ. 2002; 156: 259-261.
33. Jeon JY, Meyerhardt JA,. Energy in and energy out: what matters for survivors of colorectal cancer? J Clin Oncol. 2012; 30: 7-10.
34. Pollak MN, Schernhammer ES, Hankinson SE,. Insulin-like growth factors and neoplasia. Nat Rev Cancer. 2004; 4: 505-518.
35. Tilg H, Moschen AR,. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006; 6: 772-783.
36. Olefsky JM, Glass CK,. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol. 2010; 72: 219-246.
37. Subbaramaiah K, Howe LR, Bhardwaj P, et al. Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev Res (Phila). 2011; 4: 329-346.
38. Morris PG, Hudis CA, Giri D, et al. Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res (Phila). 2011; 4: 1021-1029.
39. Subbaramaiah K, Morris PG, Zhou XK, et al. Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women. Cancer Discov. 2012; 2: 356-365.
40. Kekatpure VD, Boyle JO, Zhou XK, et al. Elevated levels of urinary prostaglandin E metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patients. Cancer Prev Res (Phila). 2009; 20: 20.
41. Morris PG, Zhou XK, Milne GL, et al. Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging, and lung metastases in patients with breast cancer. Cancer Prev Res (Phila). 2013; 6: 428-436.
42. Ligibel JA, Goodwin PJ,. NEW and RENEW: Building the case for weight loss in breast cancer. J Clin Oncol. 2012; 30: 2294-2296.